key: cord-0770230-6mav9xqg
authors: Cajigas, Sebastian; Alzate, Daniel; Fernández, Maritza; Muskus, Carlos; Orozco, Jahir
title: Electrochemical genosensor for the specific detection of SARS-CoV-2
date: 2022-08-01
journal: Talanta
DOI: 10.1016/j.talanta.2022.123482
sha: 77fabc0d74f9c368b5614da2cc5b55936de92e62
doc_id: 770230
cord_uid: 6mav9xqg

Infection caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is responsible for the Coronavirus disease (COVID-19) and the current pandemic. Its mortality rate increases, demonstrating the imperative need for acute and rapid diagnostic tools as an alternative to current serological tests and molecular techniques. Features of electrochemical genosensor devices make them amenable for fast and accurate testing closer to the patient. This work reports on a specific electrochemical genosensor for SARS-CoV-2 detection and discrimination against homologous respiratory viruses. The electrochemical biosensor was assembled by immobilizing thiolated capture probes on top of maleimide-coated magnetic particles, followed by specific target hybridization between the capture and biotinylated signaling probes in a sandwich-type manner. The probes were rigorously designed bioinformatically and tested in vitro. Enzymatic complexes based on streptavidin-horseradish peroxidase linked the biotinylated signaling probe to render the biosensor electrochemical response. The genosensor showed to reach a sensitivity of 174.4 μA fM(−1) and a limit of detection of 807 fM when using streptavidin poly-HRP20 enzymatic complex, detected SARS-CoV-2 specifically and discriminated it against homologous viruses in spiked samples and samples from SARS-CoV-2 cell cultures, a step forward to detect SARS-CoV-2 closer to the patient as a promising way for diagnosis and surveillance of COVID-19.

Human coronavirus (HCoVs) were discovered in the 1960s, and since then, more HCoVs have been reported, including SARS-CoV, Middle East Respiratory Syndrome (MERS), with a high potential to induce fatal respiratory disease in humans [1] . Unlike alfa-coronavirus such as HCoVOC43, HCo229E, HCoNL63, and Human Coronavirus (HKU1) that have been shown to cause common cold symptoms in immunocompetent humans, SARS-CoV and MERS-CoV induce severe respiratory failure [2] and high mortality rate [3] . At the end of 2019, a novel Coronavirus (SARS-CoV-2) spread rapidly worldwide, generating a public health problem [4, 5] . This single-stranded RNA virus is responsible for COVID-19 and the current COVID-19 pandemic [6, 7] . SARS-CoV-2 is transmitted from human to human through virus-containing droplets expulsed from an infected individual by coughing, sneezing, speaking, and breathing [8] . COVID-19 infection causes respiratory, gastrointestinal, liver, and neurological failures in symptomatic patients, among other symptoms depending on each person's health status [9] .

The current clinical diagnosis of the SARS-CoV-2 is mainly based on detecting the viral RNA material through reverse transcriptase real-time Polymerase Chain Reaction (RT realtime PCR) [10, 11] . The detection of COVID-19 also deals with antigen detection by lateral flow-based assays [12] or serological tests that employ antibodies to detect immunoglobulins that result from the inflammation process caused by the SARS-CoV-2 infection [11, 13] .

Other methods include aptamer-and CRISPR-based approaches, among many others [11, 13] . Molecular techniques are considered the "gold standard" for SARS-CoV-2 detection and other pathologies involving DNA (RNA) sequence detection. Although RT-PCR is highly efficient, some drawbacks stem from the need for well-trained personnel, expensive instrumentation, time-consuming sample preparation and analysis, and lack massive availability in all world regions [14, 15] ; and serological tests may suffer from crossreactivity. In this context and because of the fast-spreading of new variants of the SARS-CoV-2, developing a simple, fast, accurate, easy-to-use, and sensitive detection tool is still an imperative need.

Biosensors have the potential to circumvent limitations of the current clinical assays in terms of portability and easiness to use near to the patient [16] , being ideal devices for pointof-care (POC) or bedside testing [15] [16] [17] . Some researchers have reported electrochemical J o u r n a l P r e -p r o o f biosensors to detect specific DNA/RNA sequences associated with viral infections [18, 19] , toxic species [20, 21] , and cancer biomarkers [22, 23] , among other pathologies [24] at low concentrations levels. However, only a few reports have detected SARS-CoV-2 with electrochemical biosensors [25, 26] , albeit no one is based on the format explored herein. For instance, an ultrasensitive electrochemical biosensor was assembled with magnetic particles decorated with gold nanoparticles and functionalized with a capture DNA probe to detect the virus in a sandwich-like format with a smartphone readout [27] . The S and N genes were detected based on isothermal rolling circle amplification with magnetic nanoparticles as sensing platform [28] and the N gene on a glassy carbon electrode functionalized with polymerized polyaniline nanowires [29] . Gold microelectrode array microchips have been combined with isothermal amplification to detect RNA-dependent polymerase and N genes [30] . Catalytic hairpin assembly with ruthenium complex was reported as a signal amplification strategy [31] . Other few authors have also reported electrochemical biosensors for N gene detection [32] for the detection of spike protein [33] [34] [35] [36] [37] [38] [39] [40] , immunoglobulins IgG and IgM [15] , and pseudotyped viral particles [41, 42] . An immunosensor [43] and a peptidebased biosensor [44] were recently reported by our group to rapidly detect the spike protein and the viral particles in clinical samples with simple electrochemical formats and values correlated with the RT-PCR standard method.

This work reports on an electrochemical biosensor for the specific detection of SARS-CoV-2 and discrimination against SARS-CoV, MERS, and HKU1 homologous viruses. All SARS-CoV-2 genomes reported in the databases were screened by a step-by-step rigorous bioinformatic protocol to select the conserved target regions [17] and design some forward and reverse primers, whose amplification capacity and specificity were verified in vitro.

Capture and signaling probes were also designed from the target sequences for the biosensor construction. The biosensor was assembled on maleimide-modified magnetic beads (MMB) by binding thiolated capture probes that hybridized first the target and later the biotinylated signaling probe in a sandwich-type format. The biotinylated signaling probe allows the interaction with one of three different protein-enzyme complexes that contain a different number of HRP molecules to produce the final biosensor response by chronoamperometry.

The electrochemical genosensor demonstrated the ability to discriminate SARS-CoV-2 when tested against SARS-CoV, MERS, and HKU1 homologous viruses and detected the genetic J o u r n a l P r e -p r o o f material in samples coming from SARS-CoV-2 cell cultures. The proposed biosystem holds the potential to detect genetic material in infected patients and asymptomatic individuals and is a step forward in developing highly sensitive genosensors to fight against the COVID-19 pandemic.

The supporting information (S.I) section contains all reagents, SARS-CoV-2 probes, solutions, and equipment for the biosensing platform's development and characterization.

The activation process of screen-printed gold electrodes (SPAuE) for biosensor development was carried out based on our previous works [17, 18] . Bioinformatic design of the specific SARS-CoV-2 probes, screening procedure of the main parameters involved in the genosensing platform, and denaturation of RNA genetic material from cell culture are summarized in the S.I section below.

An exhaustive search of all sequences deposited in the Genbank database from the National Center for Biotechnology Information (NCBI) was achieved first. The SARS-CoV-2 whole-genome sequences were screened from the beginning of the pandemic until April the 24 th , 2020, resulting in 1112 conserved genomes selected and downloaded in fasta format.

The downloaded genomic sequences were compiled as a "multifasta" file and aligned by the bioinformatic server Clustal Omega/Multiple Sequence Alignment. Jalview and Bioedit software allowed us to align and choose the most conserved regions of SARS-CoV-2 genomes, all coming from Homo Sapiens Sapiens samples [17] .

The main parameters involved in the biosensor assembly, such as the number of particles, enzyme complex-, target-, and signaling probe-concentrations, were optimized.

The biosensing platform was built by linking a sulphydryl-reactive capture probe onto maleimide-functionalized magnetic beads. In a sandwich-like format, the modified particles hybridized the target probe with a biotinylated signaling probe. An enzymatic complex acting as a labeling tag was then anchored to the signaling probe to complete the biosensing platform. A commercial TMB solution containing 10 mM H2O2 was then added and the J o u r n a l P r e -p r o o f system was kept stirring at 800 rpm and room temperature for 20 minutes. The reaction solution produced a color change measured on a Thermo Scientific Microplate Spectrophotometer (VARIOSKAN LUX) at a wavelength of 620 nm that was target concentration-dependent, serving as a rapid screening method of all variables mentioned. In the electrochemical genosensors, the response came from the TMB reduction by applying a constant voltage of -150 mV for 60 s in a potentiostat PalmSens3 with software PSTrace version 5.8. The synthetic DNA strands of SARS-CoV-2 (strain from Wuhan) and the same sequence with one and two mismatches were evaluated, and those from its SARS-CoV, MERS and HKU1 homologous are described in Table 1 .

We first evaluated the specificity of the biosensor by testing one and two base mismatches (mismatch 1 and mismatch 2) from the H conserved region of SARS-CoV-2 against SARS-CoV, MERS, and HKU1 counterparts at two different target concentrations (see Table 1 ). Similarly, by employing the same procedure for synthetic DNA, we challenged the genosensing platform with a real RNA sample from a cell culture with a total RNA/DNA load of 36.8 ng/mL (1.89 pM).

Numerical data were expressed as the mean ± standard deviation (SD) and compared statistically using Student's t-test or one-way ANOVA followed by the Bonferroni test, with p < 0.05 indicating significance and the GraphPad Prism 5.01 version for Windows (GraphPad Software, San Diego, CA, USA, 2007).

Genosensors are devices based on nucleotide sequences that act as bioreceptors for the specific biorecognition of complementary DNA/RNA target probes. The biorecognition event is commonly achieved in a sandwich-type assembly by the Watson and Crick complementarity between nitrogenous bases from bioreceptors and target sequences in hybridization conditions. The genosensor was assembled on top of MMB by linking a thiollabeled capture probe by a covalent bound [45] . Then, the viral RNA target sequence was hybridized between the thiolated capture probe and a biotinylated signaling probe. Three J o u r n a l P r e -p r o o f different protein-enzyme complexes -i.e., streptavidin-HRP, streptavidin poly-HRP20 or streptavidin poly-HRP80, containing a different quantity of HRP molecules were specifically bonded with biotin from the signaling probe to complete the biosensing platform. Finally, the biosensor performance was interrogated with TMB, an HRP enzyme-substrate, by following its oxidized colored product in the presence of hydrogen peroxide. The color change followed by spectrophotometry rapidly screened all the genosensor assembly variables detailed in the experimental section. Besides, the oxidized product was electrochemically reduced by transferring the magnetic bead-based biosensor assembly to the surface of an SPAuE and recording the current signal resulting from the TMB-electrode charge transfer after applying a cathodic potential, which was DNA(RNA) concentrationdependant.

After downloading and aligning the SARS-CoV-2 genome sequences, excluding gaps and sequence incompatibilities, 1104 genomic sequences were employed to search for the conserved regions. The first screening was based on having at least 70 nucleotides in length as minimal sequence extension, where 52 conserved sequences were identified and screened by Blast nucleotide to find the conserved sequences that do not match with previously reported coronaviruses. Next, the selected SARS-CoV-2 conserved regions' homology was interrogated against alfa-coronavirus HCoV-NL63, HCoV229E, HCoVOC43, HCoVHKU, MERS, and SARS-CoV, and the human genome, demonstrating not to present homology among all tested genomes. Finally, we selected three phylogenetically conserved regions with an appropriate length range from 18 to 25 nucleotides and fulfilled all thermodynamic requirements [17] . We designed 3'end thiolated capture probes and 5'end biotinylated signaling probes for each target's genosensor assembly as a template. Table 1 summarizes the selected conserved target regions, the designed capture and signaling probes, the sequences of homologous SARS-CoV-2, and one and two base pair mismatches concerning the SARS-CoV-2 H-conserved sequence. 

The following experiments describe optimizing the main variables involved in the electrochemical genosensor assembly rapidly screened by spectrophotometry. First, the quantity of MMB, enzyme, capture, and signaling probes concentration were optimized with a fixed concentration of the H-conserved target region of the SARS-CoV-2 of 0.1 µM (see the sequence in Table 1 ). Next, the concentration of MMB was interrogated from 0 to 30 µg. Figure 1A shows that the biosensor reached a plateau after 10 µg of MMB, indicating the saturation of colorimetric signal response. The particle concentration higher than 10 µg did not show any signal improvement; hence 10 µg of MMB was established as the optimal particle concentration for further optimizations. The streptavidin poly-HRP enzymatic complex's concentration, responsible for the signal biosensor response, was tested in concentrations from 0 to 200 ng/mL. The results indicate that the colorimetric response of the biosensor increased as the enzyme did. Nevertheless, concentrations higher than 16.6 ng/mL did not follow the Beer-Lambert law [46] , being such concentration selected as optimal (see Figure 1B) . Finally, concentrations of the thiolated capture probe coupled to the MMB surface and the biotinylated signaling probe linked to the streptavidin poly-HRP complex were tested from 0 to 0.5 µM. Figures 1C and 1D show the signal response reached J o u r n a l P r e -p r o o f a plateau with concentrations of capture and signaling probes equal to or higher than 0.1 µM, respectively, selected as the optimal concentrations. Interestingly, higher concentrations in both cases did not show any signal enhancement. As shown in Table 1 , two additional pairs of capture and signaling probes (I and A) were designed similarly to those detailed in the previous section to bind to I and A conserved regions of SARS-CoV-2, respectively. The capture and signaling probes were tested in the same concentration range as per target H, as shown in Figures S1A and S1B , with identical results. It indicates that optimal capture and signaling probes are similar for all conserved regions and that the system is highly reproducible. Table 2 summarizes the optimized parameters in the biosensor development screened by colorimetric measurements. After optimizing the genosensing assembly, it was challenged with different target concentrations of SARS-CoV-2 sequences, employing two different enzymatic streptavidin-HRP conjugates. Figure 1E shows the resulting colorimetric calibration curve in an Hconserved SARS-CoV-2 target-dependent manner from 0 to 3000 pM and Figure 1F shows Such conjugate contains 100 HRP molecules per streptavidin molecule, which is expected to amplify the signal response dramatically. Figure S3A shows the colorimetric response by testing different target concentrations ranging from 0 to 600 pM and Figure S3B shows the corresponding linear region. Table 2 summarizes the analytical parameters for the screening colorimetric assays. Results demonstrate that the sensitivity of the H-conserved region genosensor with streptavidin-poly-HRP20 increased 15-fold concerning its streptavidin-HRP counterpart. The complex also demonstrated to lower the LOD 12-fold notwithstanding a narrower working range. 

Towards developing a portable, easy-to-use genosensor with minimal consumption of reagents and samples and a direct sample readout closer to the patient, we moved to an electrochemical format. The MMB-based genonsensing assembly was confined onto the surface of the SPAuE by a magnet to test its performance in a portable and easy-to-use electrochemical workstation. Optimal enzyme, capture, and signaling probe concentrations were verified with the H-conserved region of SARS-CoV-2 genetic material by chronoamperometry. Noticeably, the enzyme complex was optimized based on the S/N, and several washing steps were implemented during particle sensitization and before the final measurements to prevent non-specific interactions that may induce a dramatic high signal background. A set of streptavidin-HRP conjugates, including streptavidin-HRP, streptavidin poly-HRP20, and streptavidin poly-HRP80, containing 1, 100, and 400 molecules of HRP per each streptavidin molecule, respectively, were compared to select the one of higher signal amplification capability [47] . Figures 2A, S3A , and S3B show results from the three different enzymatic complexes tested with 0 to 100 ng/mL, including a negative control with water instead of viral genetic material. Based on the signal/noise (S/N) ratio, the optimal enzyme concentration was 66.7 ng/mL for all cases because of the lower standard deviation of the resultant signals, and it spends a reasonable amount of this reagent while still having a high enough positive signal with low background. Yet, based on the three enzymatic complexes studied, streptavidin-HRP showed the lowest signal amplification response at the optimal enzyme concentration of 66.7 ng/mL. In contrast, streptavidin poly-HRP20 and streptavidin poly-HRP80 reached a similar maximum current value, but streptavidin poly-HRP20 had a lower background. The capture and signaling probes concentration were double-checked from 0 to 0.5 µM. It was confirmed that 0.1 µM streptavidin poly-HRP20 was the optimal enzyme complex and concentration in both cases as a signaling tag (Figures 2B and 2C) concerning the streptavidin-HRP and streptavidin poly-HRP80 counterparts. Figures S4Aand S4B show optimization of the capture probe and signaling probes with streptavidin-HRP and streptavidin poly-HRP80, respectively. The results showed a good correlation between spectrophotometry and chronoamperometry measurements, indicating that the genosensor assembly's signal response could be followed by either method on a laboratory bench or closer to the patient, respectively. The optimized parameters in the electrochemical biosensing platform are summarized in Table 3 . 

Enzyme concentration (ng/ml) 0 -100 66. probe diffusion process related to enzyme complex accumulation at the magnetic beads. Yet, as interpolation of current intensity was after 60 s, the stationary state was ensured, and the reproducibility and reliability of the results were guaranteed. The electrochemical biosensor exhibited a broader linear range using streptavidin-HRP to amplify the signal than the other enzymatic complexes studied. However, streptavidin poly-HRP20 and streptavidin-poly-HRP80 exhibited improved sensitivity and LOD concerning streptavidin-HRP. For example, the sensitivity of the genosensor amplified with streptavidin poly-HRP20 and streptavidin poly-HRP80 was ~ 62-and 91-fold higher than that of streptavidin-HRP. Consequently, the LODs went down ~ 75-and 100-fold, respectively. It demonstrated streptavidin poly-HRP20

and streptavidin poly-HRP80 comparable performance but better than streptavidin-HRP.

The higher HRP molecules of streptavidin poly-HRP80 concerning the streptavidin poly-HRP20 enzymatic complex expect the highest electrochemical biosensing signal response [44] ; however, the biosensing response was quite comparable in both cases. We hypothesized that having a complex with a higher number of molecules as a signaling tag may induce steric repulsion, limiting the contact of streptavidin poly-HRP80 complex with the biotinylated signaling probes, leading to a slightly reduced biosensing response to streptavidin-HRP20. Besides, non-specific interactions of enzymatic complexes with higher HRP molecules may produce higher backgrounds [47] (see Figures 2A and S4B ). Literature reports support well-distributed capture probes significantly influence the final biosensing response [47] [48] [49] . Such biosensors showed tetrahedral capture DNA probes to improve the capture probe distribution on the biosensor's surface. The tetrahedral DNA nanostructure reduced steric repulsion and helped minimize the background due to its capacity to act as a resistant protein [47, 50] . For the above, we choose streptavidin poly-HRP20 as the optimal enzymatic complex for the electrochemical genosensor despite the slightly lower signal

response, yet it reached the lowest background. Table 3 

The feasibility of the as-developed electrochemical genosensing platform to specifically detect the SARS-CoV-2 was interrogated. For this purpose, the electrochemical biosensing platform's potential to discriminate one and two mismatches in DNA synthetic sequences from SARS-CoV-2 and sequences from other related coronaviruses was evaluated. The electrochemical platform was tested against one and two base pair mismatches from the H-conserved region of SARS-CoV-2 and SARS-CoV, MERS, and HKU1 homologous counterparts, with three loads of target DNA sequences of 10, 100 and 1000 pM and compared with negative controls (NC) which consisted of only a buffer solution. Figure   4A shows that the current response of the genosensor for the SARS-CoV-2 DNA sequence was dramatically higher than that of the NC, the one and two base pair mismatches, and the other coronaviruses with three loads. A paired t-test and a 1-way ANOVA showed statistically significant differences, p-value < 0.05. Furthermore, the signal intensity of the genosensors with one and two mismatches was slightly higher than those from the other 

We reported an electrochemical genosensor for the specific detection of SARS-CoV-2 and discrimination against SARS-CoV, MERS, and HKU1 homologs viruses. After an exhaustive and rigorous bioinformatic analysis, we designed three pairs of thiolated capture and biotinylated signaling probes for the SARS-CoV-2 electrochemical genosensor development. We assembled the genosensor, tested the proper probe design and optimized all other parameters needed. We tested the analytical performance of the resultant electrochemical genosensor by using three different enzymatic complexes, streptavidin-HRP streptavidin poly-HRP20, and streptavidin poly-HRP80. Enzymatic complexes containing more than one HRP molecule per streptavidin molecule demonstrated to decrease the LOD from the pM to fM level. However, streptavidin-poly-HRP20 was the optimal signaling tag for the electrochemical genosensor assembly with a lowered current background. *** *** Furthermore, we demonstrated the electrochemical genosensor discriminated SARS-CoV2 against one and two base pairs mismatch from H-conserved region, SARS-CoV, MERS, and HKU1 sequences. Finally, the device detected RNA SARS-CoV-2 from cell culture concerning a negative control without genetic material. Overall, the results demonstrated that the genosensor platform could be an easy-to-use SARS-CoV-2 diagnostic tool with great potential to help in fighting the current pandemics. 

The authors declare there is no conflict of interest.

This work has been funded by Ministerio de ciencia y tecnología MINCIENCIAS 

Genetic Recombination, and Pathogenesis of Coronaviruses

Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles

Current and Perspective Diagnostic Techniques for COVID-19

The proximal origin of SARS-CoV-2

Diagnostic methods and potential portable biosensors for coronavirus disease

Presymptomatic transmission of SARS-CoV-2-Singapore

Characteristics of SARS-CoV-2 and COVID-19

Reducing transmission of SARS-CoV-2, Science (80-. )

The SARS-CoV-2 outbreak: What we know

SARS-CoV-2 detection, viral load and infectivity over the course of an infection: SARS-CoV-2 detection, viral load and infectivity

Strategies and perspectives to develop SARS-CoV-2 detection methods and diagnostics

COVID-19 diagnosis -A review of current methods

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

opvCRISPR: One-pot visual RT-LAMP-CRISPR platform for SARS-cov-2 detection

Paper-based electrochemical biosensor for diagnosing COVID-19: Detection of SARS-CoV-2 antibodies and antigen

Point-of-care devices for pathogen detections: The three most important factors to realise towards commercialization

COVID-19: A challenge for electrochemical biosensors

Genosensor for differential detection of Zika virus

Gold nanoparticle/DNA-based nanobioconjugate for electrochemical detection of Zika virus

Electrochemical RNA genosensors for toxic algal species: enhancing selectivity and sensitivity

Electrochemical performance of a DNA-based sensor device for detecting toxic algae

Dual-mode electrochemical analysis of microRNA-21 using gold nanoparticledecorated MoS2 nanosheet

Multiple Amplified Electrochemical Detection of MicroRNA-21 Using Hierarchical Flower-like Gold Nanostructures Combined with Gold-enriched Hybridization Chain Reaction

Label-Free and Ultrasensitive Electrochemical DNA Biosensor Based on Urchinlike Carbon Nanotube-Gold Nanoparticle Nanoclusters

Opportunities and Challenges for Biosensors and Nanoscale Analytical Tools for Pandemics: COVID-19

The potential of electrochemistry for the detection of coronavirus-induced infections

Ultrasensitive supersandwich-type electrochemical sensor for SARS-CoV-2 from the infected COVID-19 patients using a smartphone

Rapid electrochemical detection of coronavirus SARS-CoV-2

Electrochemical Biosensor with Enhanced Antifouling Capability for COVID-19 Nucleic Acid Detection in Complex Biological Media

Sensitive electrochemical biosensor combined with isothermal amplification for point-of-care COVID-19 tests

An electrochemical biosensor for sensitive analysis of the SARS-CoV-2 RNA

Rapid, ultrasensitive, and quantitative detection of SARS-CoV-2 using antisense oligonucleotides directed electrochemical biosensor chip

Development of a Portable, Ultra-Rapid and Ultra-Sensitive Cell-Based Biosensor for the Direct Detection of the SARS-CoV-2 S1 Spike Protein Antigen

An electrochemical SARS-CoV-2 biosensor inspired by glucose test strip manufacturing processes

Electrochemical immunosensor with Cu2O nanocube coating for detection of SARS-CoV-2 spike protein

Rapid SARS-CoV-2 detection using electrochemical immunosensor

Functionalized TiO 2 nanotube-based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2

Development of a portable MIP-based electrochemical sensor for detection of SARS-CoV-2 antigen

3D-Printed COVID-19 immunosensors with electronic J o u r n a l P r e -p r o o f readout

Rapid and Efficient Detection of the SARS-CoV-2 Spike Protein Using an Electrochemical Aptamer-Based Sensor

Detection of SARS-CoV-2 Viral Particles Using Direct, Reagent-Free Electrochemical Sensing

Voltammetricbased immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen

SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex

Peptide-based simple detection of SARS-CoV-2 with electrochemical readout

Thiol-maleimide "click" chemistry: Evaluating the influence of solvent, initiator, and thiol on the reaction mechanism, kinetics, and selectivity

The Beer-Lambert law

Electrochemical detection of PCR amplicons of: Escherichia coli genome based on DNA nanostructural probes and polyHRP enzyme

A DNA nanostructured biosensor for electrochemical analysis of HER2 using bioconjugate of GNR@Pd SSs-Apt-HRP

An ultrasensitive electrochemical biosensor for the detection of mecA gene in methicillin-resistant Staphylococcus aureus

DNA Nanostructure-based Interfacial engineering for PCR-free ultrasensitive electrochemical analysis of microRNA

Electrochemical genosensor of SARS-CoV-2 and discrimination against homologous virus

• Specific probes rigorously designed by bioinformatics and tested in vitro. • Enhanced analytical performance by enzymatic complexes. • Rapid and reliable determination of RNA from SARS-CoV-2 cell culture

J o u r n a l P r e -p r o o f

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f